Pregnancy outcomes after maternal exposu
โ
Pia S. Pollack; Kristine E. Shields; Diane M. Burnett; Mary Jean Osborne; Michae
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 167 KB
๐ 1 views
## BACKGROUND: Our objective was to determine the frequency of adverse outcomes after maternal exposure to simvastatin and/or lovastatin during pregnancy in postmarketing experience. METHODS: We reviewed the Merck & Co., Inc. (West Point, PA) pharmacovigilance database for reports of exposure to s